drugset / Trial / NCT05900635

Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients

NCT05900635

Phase 4 Unknown 60 enrolled Alexandria University
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the effects of adding lactoferrin to the every-other-day oral iron supplementation in iron deficiency anemia and chronic kidney disease patients.

Timeline

Start
2022-10-01
Primary completion
2023-06
Completion
2023-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactoferrin Protein / enzyme biologic 100 mg Oral
Background Ferrous Glycine Sulfate Unknown 100 mg Oral